Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Future of Medicare immunosuppressive drug coverage for kidney transplant recipients in the United States.

Tanriover B, Stone PW, Mohan S, Cohen DJ, Gaston RS.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1258-66. doi: 10.2215/CJN.09440912. Epub 2013 Apr 4. Review.

2.

Cost-effectiveness of Medicare's coverage of immunosuppression medications for kidney transplant recipients.

Page TF, Woodward RS.

Expert Rev Pharmacoecon Outcomes Res. 2009 Oct;9(5):435-44. doi: 10.1586/erp.09.52. Review.

PMID:
19817527
3.

The UNOS Renal Transplant Registry: Review of the Last Decade.

Andre M, Huang E, Everly M, Bunnapradist S.

Clin Transpl. 2014:1-12. Review.

PMID:
26281122
4.

Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.

Hong T, Zhang M, Fan J.

Cochrane Database Syst Rev. 2015 Oct 12;(10):CD009698. doi: 10.1002/14651858.CD009698.pub2. Review.

PMID:
26457607
5.

Health policy, disparities, and the kidney.

Williams AW.

Adv Chronic Kidney Dis. 2015 Jan;22(1):54-9. doi: 10.1053/j.ackd.2014.06.002. Review.

PMID:
25573513
6.

Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?

Nerini E, Bruno F, Citterio F, Schena FP.

J Nephrol. 2016 Oct;29(5):627-36. doi: 10.1007/s40620-016-0273-x. Epub 2016 Feb 17. Review.

PMID:
26885659
7.

Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

Prendergast MB, Gaston RS.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1305-11. doi: 10.2215/CJN.07241009. Epub 2010 May 6. Review.

8.

Generic Drugs - Decreasing Costs and Room for Increased Number of Kidney Transplantations.

Spasovski G.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(2):133-8. doi: 10.1515/prilozi-2015-0061. Review.

PMID:
27442379
9.

Kidney transplantation: future challenges.

Veroux M, Corona D, Veroux P.

Minerva Chir. 2009 Feb;64(1):75-100. Review.

PMID:
19202537
10.

Management of the kidney transplant recipient.

Padiyar A, Akoum FH, Hricik DE.

Prim Care. 2008 Sep;35(3):433-50, v. doi: 10.1016/j.pop.2008.03.003. Review.

PMID:
18710663
11.

Outcomes in kidney transplantation.

Djamali A, Premasathian N, Pirsch JD.

Semin Nephrol. 2003 May;23(3):306-16. Review.

PMID:
12838499
12.

Renal transplantation--demystifying the process.

Cross J.

CANNT J. 2003 Jul-Sep;13(3):40-59; quiz 48-9. Review. English, French.

PMID:
14596198
13.

Health insurance considerations for adolescent transplant recipients as they transition to adulthood.

Willoughby LM, Fukami S, Bunnapradist S, Gavard JA, Lentine KL, Hardinger KL, Burroughs TE, Takemoto SK, Schnitzler MA.

Pediatr Transplant. 2007 Mar;11(2):127-31. Review.

PMID:
17300489
14.

Operational tolerance: past lessons and future prospects.

Levitsky J.

Liver Transpl. 2011 Mar;17(3):222-32. doi: 10.1002/lt.22265. Review.

15.

Recent advances in immunosuppressive therapy for renal transplantation.

Peddi VR, First MR.

Semin Dial. 2001 May-Jun;14(3):218-22. Review.

PMID:
11422929
16.

Current Status of Kidney Transplant Outcomes: Dying to Survive.

Wang JH, Skeans MA, Israni AK.

Adv Chronic Kidney Dis. 2016 Sep;23(5):281-286. doi: 10.1053/j.ackd.2016.07.001. Review.

PMID:
27742381
17.

The economics of immunosuppression in renal transplantation: a review of recent literature.

Hutton J.

Transplant Proc. 1999 Feb-Mar;31(1-2):1328-32. Review. No abstract available.

PMID:
10083592
18.

Renal transplantation.

Ramanathan V, Goral S, Helderman JH.

Semin Nephrol. 2001 Mar;21(2):213-9. Review.

PMID:
11245782
19.

Disparities in kidney transplant outcomes: a review.

Gordon EJ, Ladner DP, Caicedo JC, Franklin J.

Semin Nephrol. 2010 Jan;30(1):81-9. doi: 10.1016/j.semnephrol.2009.10.009. Review.

20.

Pharmacoeconomics of immunosuppressive agents in renal transplant recipients.

Bennett WM, Olyaei AJ.

Transplant Proc. 1999 May;31(3A Suppl):6S. Review. No abstract available.

PMID:
10330949

Supplemental Content

Support Center